2Goasguen J E,Dossot J M,Fardel O,et al.Expression of the Multidrug Resistanance-Associated P-Glycoprotein(P-170)in 59 Cases of De Novo Acute Lymphoblastic Leukemia:Prognostic Implications[J].Blood,1993,9(1):2394-2398.
3Wattel E,Leppelley P,Merlat A,et al.Expression of the muhidrug resistance P-glycoprotein in newly diagnosed adult lymphoblastic leukemia:absense of correlation with response to treatment[J].Leukemia,1995,9:1870-1874.
4Germann UA.P-glyeoprotein-A midiator of muhidrug resistance in tumour cells[J].Eur J Cancer,1996,32:927-944.
二级参考文献4
1Taylor BJ ,Olson DP,Iw SP. Detection of P-glycoprotein in cell lines and leukemic blasts :failure of select monoclonal antibodies to detect clinically significant P-gp levels in primary cells [J]. Leuk Res,2001,25 (12): 1127 - 1135.
2Demur C, Meller C, Cassar G, et al. Acute myeloid leukemia cells with low P-glycoprotein expression and high Rhodamine123 efflux capacity display high clonogenicity [J]. Leukemia, 1998,12 ( 2 ):192 - 199.
3Leith CP,Chen IM,Kopecky KJ, et al. Correlation of multidrug resistance protein expression with functional dye/drug efflux in acute myeloid leukemia by multiparameter and MDR1 +/efflux- case[J].Blood, 1995,86 ( 6 ) :2329 - 2342.
4Filipits M, Stranzl T, Pohl G, et al. Drug resistance factors in AML: a comparative analysis[J]. Leukemia, 2000, 14 (1): 68-76.
